Skip to Main Content

Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the Pharmalot campus, where things have settled down now that the short person is hovering over a laptop and the official mascot has assumed his formal snoozing position. As for us, we are dutifully concocting a few needed cups of stimulation as we dig in for another busy day. No doubt, you can relate. So time to get cracking. As always, we have assembled some items of interest. So hoist your own cup to a successful day, and drop us a line when something interesting arises. …

Pfizer (PFE) will not try to break the bank if it develops a Covid-19 vaccine, Axios writes. “If we were to implement free, open-market principles in pricing the product, we could go to huge prices and sell everything we can manufacture. But it would be unethical, I think. We will not do it, because that’s really taking advantage of a situation, and people will not forget if you do that,” Pfizer chief executive officer Albert Bourla told a virtual conference held by Goldman Sachs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!